Patient P-01766
Synthetic patientNBL-101 · Day 118 · 45–54 · M · baseline S05Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S05
- Day 89 AD-05 recommended — Adherence Support AD-05
- Day 90 Patient accepted — Started AD-05 in the companion
- Day 95 No meaningful change — Adherence Support AD-05
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Treatment adherence+11
- Toxicity+6
- GI instability-4
- Inflammatory activity-4
What helped?
- Adherence Support AD-05Day 89Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion13/100
worsening · +0.9 vs previous 14 d
Toxicity
Blood23.6/100
worsening · +4.8 vs previous 14 d
Sleep quality
Wearable40.9/100
stable · +1.2 vs previous 14 d
Energy level
Daily log6/10
stable · +0.1 vs previous 14 d
Stress level
Daily log3.8/10
worsening · +0.3 vs previous 14 d
Steps
Wearable6,226
worsening · -298 vs previous 14 d
Adherence
Companion98.7 %
improving · +4.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 99 from the failing basin, 13 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- AD-05 Adherence Supportalready tried, no meaningful change
- Keep simple carbs lowGI +3.4 next day on high-intake days · n 21
- Keep alcohol lowGI +3.2 next day on high-intake days · n 15
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+3.4detractor · 95%
- Alcohol+3.2detractor · 81%
- Insoluble fibre-1.1no signal · 20%
- Histamine load+0.8no signal · 16%
- Spicy / capsaicin+0.5no signal · 15%
- Dietary fat load-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↓45
- WearableResting HR 74 bpm
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 65/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 54 ms
- Sleep
- 6.1 h
- Steps
- 5,533
- Resting HR
- 75 bpm
Daily log: GI score 13, nutritional resilience 67, adherence 99.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.